Oxford Gene Technology

OGT has helped pioneer the molecular medicine revolution by enabling smarter decision making in human healthcare. With customers in over 60 countries worldwide and ambitious expansion plans, OGT has a strong reputation and increasing share in the large and growing genomic medicine market. The Group's CytoSure™, Cytocell® and Genefficiency™ range of microarray, FISH and next generation sequencing products and services deliver high-quality, high-throughput genetic analysis, enabling accurate identification of the causative variation underlying genetic disease.